These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17440160)

  • 1. Potential drug interactions and duplicate prescriptions among cancer patients.
    Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
    J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug interactions in cancer patients receiving supportive care exclusively.
    Riechelmann RP; Zimmermann C; Chin SN; Wang L; O'Carroll A; Zarinehbaf S; Krzyzanowska MK
    J Pain Symptom Manage; 2008 May; 35(5):535-43. PubMed ID: 18243638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
    Lemachatti J; Levêque D; Beretz L; Bergerat JP
    Anticancer Res; 2009 Nov; 29(11):4741-4. PubMed ID: 20032429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
    Halkin H; Katzir I; Kurman I; Jan J; Malkin BB
    Clin Pharmacol Ther; 2001 Apr; 69(4):260-5. PubMed ID: 11309555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and patient awareness of selected potential drug interactions with self-medication.
    Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for drug interactions in hospitalized cancer patients.
    Riechelmann RP; Moreira F; Smaletz O; Saad ED
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):286-90. PubMed ID: 15731916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use?
    Frank C; Godwin M; Verma S; Kelly A; Birenbaum A; Seguin R; Anderson J
    Can Fam Physician; 2001 Jun; 47():1198-204. PubMed ID: 11421047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the value of electronic prescribing in ambulatory care: a focus group study.
    Weingart SN; Massagli M; Cyrulik A; Isaac T; Morway L; Sands DZ; Weissman JS
    Int J Med Inform; 2009 Sep; 78(9):571-8. PubMed ID: 19395307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
    Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy.
    Kotirum S; Chaiyakunapruk N; Jampachaisri K; Wattanasombat S; Rojnuckarin P
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):216-22. PubMed ID: 16874847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of potential drug interactions among patients receiving anti-hypertensive medications.
    Sweileh WM; Sawalha AF; Jaradat NA
    Saudi Med J; 2005 Apr; 26(4):548-52. PubMed ID: 15900357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.
    Janchawee B; Wongpoowarak W; Owatranporn T; Chongsuvivatwong V
    J Clin Pharm Ther; 2005 Feb; 30(1):13-20. PubMed ID: 15659000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interactions in oncology: why are they important and can they be minimized?
    Blower P; de Wit R; Goodin S; Aapro M
    Crit Rev Oncol Hematol; 2005 Aug; 55(2):117-42. PubMed ID: 15890526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.